Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-24 @ 2:06 PM
NCT ID:
NCT07099495
Eligibility Criteria:
Inclusion Criteria:
* Individuals of both sexes;
* Age ≥ 18 years;
* Diagnosis of chronic HF;
* Symptoms compatible with Functional Class (FC) III-IV of the New York Heart Association (NYHA);
* Stable condition on pharmacological therapy;
* Absence of Acute Myocardial Infarction in the last three months prior to participant recruitment;
* Absence of an automatic internal cardioverter defibrillator (ICD) or cardiac pacemaker;
Exclusion Criteria:
* Individuals with hemodynamic instability, unstable angina, acute myocardial infarction during the period of application of the protocol and diagnosis of hypertrophic cardiomyopathy during the period of application of the protocol;
* Individuals with recent muscle or tendon injuries, muscular dystrophies, myopathies, unstable fractures, infections or deep vein thrombosis (DVT);
* Chronic need for oxygen therapy;
* Absence in reassessments;
* Refusal to participate in the research after its beginning.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07099495
Study Brief:
Protocol Section:
NCT07099495